Primary thromboprophylaxis in cancer outpatients - real-world evidence

• Type: Article in International Scientific Journal
• Date: 2024

Authors

Liz Pimenta, J (Author) Other; Tavares, V (Author) Other; Gramaca, J (Author) Other; Rato, J (Author) Other; Menezes, M (Author) Other; Baleiras, M (Author) Other; Guedes, H (Author) Other; Reis, J (Author) Other; Guedes, C (Author) Other; Gomes, R (Author) Other; Barbosa, M (Author) Other; Sousa, M (Author) Other; Khorana, AA (Author) Other; Rui Medeiros (Author) ICBAS

Journal

Title: Journal of Thrombosis and Thrombolysis

ISSN: 0929-5305

Publisher: Springer Nature

Indexing

ISI Web of Knowledge - 0 Citations

Scopus - 0 Citations

Other information

Authenticus ID: P-010-BQW

DOI: 10.1007/s11239-024-02984-1

Abstract (EN): IntroductionCancer-associated thrombosis (CAT) is a significant concern among patients with malignant diseases, leading to increased mortality. While current guidelines recommend primary thromboprophylaxis for venous thromboembolism (VTE) in medium-to-high-risk outpatients, this practice remains controversial. A better understanding of primary thromboprophylaxis is crucial, yet there is a lack of Real-World Evidence (RWE) in Portugal.AimsThis RWE study aimed to elucidate primary thromboprophylaxis practices among cancer outpatients in Portugal.MethodsA five-year observational multicentric study in eight Portuguese health institutions enrolled 124 adult cancer outpatients under primary thromboprophylaxis for VTE. The endpoints were CAT, bleeding, cancer progression and death.ResultsHigh thrombotic risk tumours were prevalent, with 57% (71) of the patients presenting with pancreatic and gastric cancers. Regarding primary thromboprophylaxis, 55% (68) received Low-Molecular-Weight Heparin (LMWH). VTE was presented in 11% (14) of the patients and major bleeding in 2% (2). Vascular compression, elevated D-dimer and previous VTE were significantly associated with VTE occurrence under primary thromboprophylaxis. The Onkotev model was shown to be the best risk assessment model (RAM) in this population (p = 0.007). CAT patients exhibited a lower progression-free survival than non-CAT patients (p = 0.021), while thrombosis did not influence overall survival (p = 0.542).ConclusionPrimary thromboprophylaxis in medium-to-high-risk cancer outpatients is a safe and effective practice in real-world settings. This study is the first Portuguese RWE on primary thromboprophylaxis, highlighting evidence for improving prophylactic strategies in this population.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 10